Global Connected Wearable Patches Market was valued US$ 1.3Bn in 2017 and is anticipated to reach US$ 37.39Bn by 2026 at a CAGR of about 37.39% during a forecast.
Global Connected Wearable Patches is segmented by Product Type, by Application and by region. Based on Product Type, Connected Wearable Patches is divided into Clinical Use & Non-Clinical Use. By Application are classified in Monitoring, Detection and Diagnosis, Managing and Treatment, Health, Wellness and Prevention & Clinical Trials. Geographically into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Driving factors for the connected wearable patches is increasing concern among people related to their health, patients can monitor their own health from home or on the go, educating themselves and making own decisions on issues that affect their bodies, access to in-depth information when monitoring a chronic disease or making a diagnosis and lower the healthcare costs will make more demand in connected wearable patches.
Limited functionality and low level of comfort can hamper the growth of Connected Wearable Patches.
In terms of Product Type, Clinical Use segment share highest market during the forecast period. In clinical it helps to gather information at regular intervals and transmit the data to connected devices such as smartphones and laptops, physicians and nurses have access to a real-time, continuous flow of data, allowing trends to be detected, which can prevent patient deterioration. Technological advancement to enhance the connected wearable patches with more features and data accuracy is expected to bring new growth opportunities for the market in the coming future.
Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increasing demand for technologically advanced medical devices and monitoring devices that can be used in homes for the growing aging population, rise in demand for improved lifestyle and rising health concern and pollution in Asia Pacific will have more opportunities in these region.
iRhythm, Sensium Healthcare, Vancive Medical, Medtronic/Zephyr Technology, G-Tech Medical, Gentag Inc., Preventice Inc., Proteus Digital Health, DexCom, Abbott Laboratories, Bloomlife, Chrono Therapeutics, Dexcom, Eccrine Clinical Use, Feeligreen, Gentag, Isansys Lifecare, Kenzen, Leaf Healthcare, MC10, Medtronic, Nemaura Medical, Philips Healthcare, Preventice Technologies, Proteus Digital, Qualcomm Life, TempTraq (Blue Spark Technologies), Theranica Bio-Electronics, Vancive Medical Technologies, VitalConnect.
scope of the Global Connected Wearable Patches Market:
Global Connected Wearable Patches: By Product Type
Clinical Use
Non-Clinical Use
Global Connected Wearable Patches: By Application
Monitoring, Detection and Diagnosis
Managing and Treatment
Health,
Wellness and Prevention
Clinical Trials
Global Connected Wearable Patches: By region
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Key Player analysed in Global Connected Wearable Patches Market:
iRhythm
Sensium Healthcare
Vancive Medical
Medtronic/Zephyr Technology
G-Tech Medical
Gentag Inc.
Preventice Inc.
Proteus Digital Health
DexCom
Abbott Laboratories
Bloomlife
Chrono Therapeutics
Dexcom
Eccrine systems
Feeligreen
Gentag
G-Tech Medical
Isansys Lifecare
Kenzen
Leaf Healthcare
MC10
Medtronic
Nemaura Medical
Philips Healthcare
Preventice Technologies
Proteus Digital
Qualcomm Life
TempTraq (Blue Spark Technologies)
Theranica Bio-Electronics
Vancive Medical Technologies
VitalConnect
Global Connected Wearable Patches Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlight
1.3. Research Objectives
1.4. Key Questions Answered
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Connected Wearable Patches Size, By Market Value (US$ Mn) and Market , By Region
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
5. Global Connected Wearable Patches Analysis and Forecast
5.1. Global Connected Wearable Patches Analysis and Forecast
5.2. Global Connected Wearable Patches Size & Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America
6. Global Connected Wearable Patches Analysis and Forecast, By Product Type
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Connected Wearable Patches Value Share Analysis, By Product Type
6.4. Global Connected Wearable Patches Size (US$ Mn) Forecast, By Product Type
6.5. Global Connected Wearable Patches Analysis, By Product Type
6.6. Global Connected Wearable Patches Attractiveness Analysis, By Product Type
7. Global Connected Wearable Patches Analysis and Forecast, By Application
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Connected Wearable Patches Value Share Analysis, By Application
7.4. Global Connected Wearable Patches Size (US$ Mn) Forecast, By Application
7.5. Global Connected Wearable Patches Analysis, By Application
7.6. Global Connected Wearable Patches Attractiveness Analysis, By Application
8. Global Connected Wearable Patches Analysis, By Region
8.1. Key Findings
8.2. Global Connected Wearable Patches Value Share Analysis, By Region
8.3. Global Connected Wearable Patches Size (US$ Mn) Forecast, By Region
8.4. Global Connected Wearable Patches Analysis, By Region
8.5. Global Connected Wearable Patches Attractiveness Analysis, By Region
9. North America Connected Wearable Patches Analysis
9.1. North America Connected Wearable Patches Overview
9.2. North America Connected Wearable Patches Value Share Analysis, By Product Type
9.3. North America Connected Wearable Patches Forecast, By Product Type
9.3.1. Clinical Use
9.3.2. Non-Clinical Use
9.4. North America Connected Wearable Patches Value Share Analysis, By Application
9.5. North America Connected Wearable Patches Forecast, By Application
9.5.1. Monitoring, Detection and Diagnosis
9.5.2. Managing and Treatment
9.5.3. Health,
9.5.4. Wellness and Prevention
9.5.5. Clinical Trials
9.6. North America Connected Wearable Patches Value Share Analysis, By Country
9.7. North America Connected Wearable Patches Forecast, By Country
9.7.1.1. U.S.
9.7.1.2. Canada.
9.8. U.S. Connected Wearable Patches Forecast, By Product Type
9.8.1. Clinical Use
9.8.2. Non-Clinical Use
9.9. U.S. Connected Wearable Patches Forecast, By Application
9.9.1. Monitoring, Detection and Diagnosis
9.9.2. Managing and Treatment
9.9.3. Health,
9.9.4. Wellness and Prevention
9.9.5. Clinical Trials
9.10. Canada Connected Wearable Patches Forecast, By Product Type
9.10.1. Clinical Use
9.10.2. Non-Clinical Use
9.11. Canada Connected Wearable Patches Forecast, By Application
9.11.1. Monitoring, Detection and Diagnosis
9.11.2. Managing and Treatment
9.11.3. Health,
9.11.4. Wellness and Prevention
9.11.5. Clinical Trials
9.12. North America Connected Wearable Patches Attractiveness Analysis
9.12.1. By Product Type
9.12.2. By Application
9.13. PEST Analysis
10. Europe Global Connected Wearable Patches Analysis
10.1. Key Findings
10.2. Europe Connected Wearable Patches Overview
10.3. Europe Connected Wearable Patches Value Share Analysis, By Product Type
10.4. Europe Connected Wearable Patches Forecast, By Product Type
10.4.1. Clinical Use
10.4.2. Non-Clinical Use
10.5. Europe Connected Wearable Patches Value Share Analysis, By Application
10.6. Europe Connected Wearable Patches Forecast, By Application
10.6.1. Monitoring, Detection and Diagnosis
10.6.2. Managing and Treatment
10.6.3. Health,
10.6.4. Wellness and Prevention
10.6.5. Clinical Trial
10.7. Europe Connected Wearable Patches Forecast, By Country
10.7.1. Germany
10.7.2. U.K.
10.7.3. France
10.7.4. Italy
10.7.5. Spain
10.7.6. Rest of Europe
10.8. Europe Connected Wearable Patches Analysis, By Country/ Sub-region
10.9. Germany Connected Wearable Patches Forecast, By Product Type
10.9.1. Clinical Use
10.9.2. Non-Clinical Use
10.10. Germany Connected Wearable Patches Forecast, By Application
10.10.1. Monitoring, Detection and Diagnosis
10.10.2. Managing and Treatment
10.10.3. Health,
10.10.4. Wellness and Prevention
10.10.5. Clinical Trials
10.11. U.K. Connected Wearable Patches Forecast, By Product Type
10.11.1. Clinical Use
10.11.2. Non-Clinical Use
10.12. U.K. Connected Wearable Patches Forecast, By Application
10.12.1. Monitoring, Detection and Diagnosis
10.12.2. Managing and Treatment
10.12.3. Health,
10.12.4. Wellness and Prevention
10.12.5. Clinical Trials
10.13. France Connected Wearable Patches Forecast, By Product Type
10.13.1. Clinical Use
10.13.2. Non-Clinical Use
10.14. France Connected Wearable Patches Forecast, By Application
10.14.1. Monitoring, Detection and Diagnosis
10.14.2. Managing and Treatment
10.14.3. Health,
10.14.4. Wellness and Prevention
10.14.5. Clinical Trials
10.15. Italy Connected Wearable Patches Forecast, By Product Type
10.15.1. Clinical Use
10.15.2. Non-Clinical Use
10.16. Italy Connected Wearable Patches Forecast, By Application
10.16.1. Monitoring, Detection and Diagnosis
10.16.2. Managing and Treatment
10.16.3. Health,
10.16.4. Wellness and Prevention
10.16.5. Clinical Trials
10.17. Spain Connected Wearable Patches Forecast, By Product Type
10.17.1. Clinical Use
10.17.2. Non-Clinical Use
10.18. Spain Connected Wearable Patches Forecast, By Application
10.18.1. Monitoring, Detection and Diagnosis
10.18.2. Managing and Treatment
10.18.3. Health,
10.18.4. Wellness and Prevention
10.18.5. Clinical Trials
10.19. Rest of Europe Connected Wearable Patches Forecast, By Product Type
10.19.1. Clinical Use
10.19.2. Non-Clinical Use
10.20. Rest of Europe Connected Wearable Patches Forecast, By Application
10.20.1. Monitoring, Detection and Diagnosis
10.20.2. Managing and Treatment
10.20.3. Health,
10.20.4. Wellness and Prevention
10.20.5. Clinical Trials
10.21. Europe Connected Wearable Patches Attractiveness Analysis
10.21.1. By Product Type
10.21.2. By Application
10.22. PEST Analysis
11. Asia Pacific Global Connected Wearable Patches Analysis
11.1. Key Findings
11.2. Asia Pacific Connected Wearable Patches Overview
11.3. Asia Pacific Connected Wearable Patches Value Share Analysis, By Product Type
11.4. Asia Pacific Connected Wearable Patches Forecast, By Product Type
11.4.1. Clinical Use
11.4.2. Non-Clinical Use
11.5. Asia Pacific Connected Wearable Patches Value Share Analysis, By Application
11.6. Asia Pacific Connected Wearable Patches Forecast, By Application
11.6.1. Monitoring, Detection and Diagnosis
11.6.2. Managing and Treatment
11.6.3. Health,
11.6.4. Wellness and Prevention
11.6.5. Clinical Trials
11.7. Asia Pacific Connected Wearable Patches Value Share Analysis, By Country
11.8. Asia Pacific Connected Wearable Patches Forecast, By Country
11.8.1. China.
11.8.2. India.
11.8.3. Japan.
11.8.4. ASEAN.
11.8.5. Rest of Asia Pacific.
11.9. Asia Pacific Connected Wearable Patches Analysis, By Country/ Sub-region
11.10. China Connected Wearable Patches Forecast, By Product Type
11.10.1. Clinical Use
11.10.2. Non-Clinical Use
12.13. China Connected Wearable Patches Forecast, By Application
12.13.1. Monitoring, Detection and Diagnosis
12.13.2. Managing and Treatment
12.13.3. Health,
12.13.4. Wellness and Prevention
12.13.5. Clinical Trials
12.14. India Connected Wearable Patches Forecast, By Product Type
12.14.1. Clinical Use
12.14.2. Non-Clinical Use
12.15. India Connected Wearable Patches Forecast, By Application
12.15.1. Monitoring, Detection and Diagnosis
12.15.2. Managing and Treatment
12.15.3. Health,
12.15.4. Wellness and Prevention
12.15.5. Clinical Trials
12.16. Japan Connected Wearable Patches Forecast, By Product Type
12.16.1. Clinical Use
12.16.2. Non-Clinical Use
12.17. Japan Connected Wearable Patches Forecast, By Application
12.17.1. Monitoring, Detection and Diagnosis
12.17.2. Managing and Treatment
12.17.3. Health,
12.17.4. Wellness and Prevention
12.17.5. Clinical Trials
12.18. ASEAN Connected Wearable Patches Forecast, By Product Type
12.18.1. Clinical Use
12.18.2. Non-Clinical Use
12.19. ASEAN Connected Wearable Patches Forecast, By Application
12.19.1. Monitoring, Detection and Diagnosis
12.19.2. Managing and Treatment
12.19.3. Health,
12.19.4. Wellness and Prevention
12.19.5. Clinical Trials
12.20. Rest of Asia Pacific Connected Wearable Patches Forecast, By Product Type
12.20.1. Clinical Use
12.20.2. Non-Clinical Use
12.21. Rest of Asia Pacific Connected Wearable Patches Forecast, By Application
12.21.1. Monitoring, Detection and Diagnosis
12.21.2. Managing and Treatment
12.21.3. Health,
12.21.4. Wellness and Prevention
12.21.5. Clinical Trials
12.22. PEST Analysis
13. Middle East & Africa Connected Wearable Patches Analysis
13.13. Key Findings
13.14. Middle East & Africa Connected Wearable Patches Overview
13.15. Middle East & Africa Connected Wearable Patches Value Share Analysis, By Product Type
13.16. Middle East & Africa Connected Wearable Patches Forecast, By Product Type
13.16.1. Clinical Use
13.16.2. Non-Clinical Use
13.17. Middle East & Africa Connected Wearable Patches Value Share Analysis, By Application
13.18. Middle East & Africa Connected Wearable Patches Forecast, By Application
13.18.1. Monitoring, Detection and Diagnosis
13.18.2. Managing and Treatment
13.18.3. Health,
13.18.4. Wellness and Prevention
13.18.5. Clinical Trials
13.19. Middle East & Africa Connected Wearable Patches Value Share Analysis, By Country
13.20. Middle East & Africa Connected Wearable Patches Forecast, By Country
13.20.1. GCC.
13.20.2. South Africa.
13.20.3. Rest of Middle East & Africa.
13.21. Middle East & Africa Connected Wearable Patches Analysis, By Country/ Sub-region
13.22. GCC Connected Wearable Patches Forecast, By Product Type
13.22.1. Clinical Use
13.22.2. Non-Clinical Use
13.23. GCC Connected Wearable Patches Forecast, By Application
13.23.1. Monitoring, Detection and Diagnosis
13.23.2. Managing and Treatment
13.23.3. Health,
13.23.4. Wellness and Prevention
13.23.5. Clinical Trials
13.24. South Africa Connected Wearable Patches Forecast, By Product Type
13.24.1. Clinical Use
13.24.2. Non-Clinical Use
13.25. South Africa Connected Wearable Patches Forecast, By Application
13.25.1. Monitoring, Detection and Diagnosis
13.25.2. Managing and Treatment
13.25.3. Health,
13.25.4. Wellness and Prevention
13.25.5. Clinical Trials
13.26. Rest of Middle East and Africa Connected Wearable Patches Forecast, By Product Type
13.26.1. Clinical Use
13.26.2. Non-Clinical Use
13.27. Rest of Middle East and Africa Connected Wearable Patches Forecast, By Application
13.27.1. Monitoring, Detection and Diagnosis
13.27.2. Managing and Treatment
13.27.3. Health,
13.27.4. Wellness and Prevention
13.27.5. Clinical Trials
13.28. Middle East & Africa Global Connected Wearable Patches Attractiveness Analysis
13.28.1. By Product Type
13.28.2. By Application
13.29. PEST Analysis
14. Latin America Connected Wearable Patches Analysis
14.13. Key Findings
14.14. Latin America Connected Wearable Patches Overview
14.15. Latin America Connected Wearable Patches Value Share Analysis, By Product Type
14.16. Latin America Connected Wearable Patches Forecast, By Product Type
14.16.1. Clinical Use
14.16.2. Non-Clinical Use
14.15. Latin America Connected Wearable Patches Value Share Analysis, By Application
14.17. Latin America Connected Wearable Patches Forecast, By Application
14.17.1. Monitoring, Detection and Diagnosis
14.17.2. Managing and Treatment
14.17.3. Health,
14.17.4. Wellness and Prevention
14.17.5. Clinical Trials
14.18. Latin America Connected Wearable Patches Value Share Analysis, By Country
14.19. Latin America Connected Wearable Patches Forecast, By Country
14.19.1.1. Brazil.
14.19.1.2. Mexico.
14.19.1.3. Rest of Latin America.
14.20. Latin America Connected Wearable Patches Analysis, By Country/ Sub-region
14.21. Brazil Connected Wearable Patches Forecast, By Product Type
14.21.1. Clinical Use
14.21.2. Non-Clinical Use
14.22. Brazil Connected Wearable Patches Forecast, By Application
14.22.1. Monitoring, Detection and Diagnosis
14.22.2. Managing and Treatment
14.22.3. Health,
14.22.4. Wellness and Prevention
14.22.5. Clinical Trials
14.23. Mexico Connected Wearable Patches Forecast, By Product Type
14.23.1. Clinical Use
14.23.2. Non-Clinical Use
14.24. Mexico Connected Wearable Patches Forecast, By Application
14.24.1. Monitoring, Detection and Diagnosis
14.24.2. Managing and Treatment
14.24.3. Health,
14.24.4. Wellness and Prevention
14.24.5. Clinical Trials
14.25. Rest of Latin America Connected Wearable Patches Forecast, By Product Type
14.25.1. Clinical Use
14.25.2. Non-Clinical Use
14.26. Rest of Latin America Connected Wearable Patches Forecast, By Application
14.26.1. Monitoring, Detection and Diagnosis
14.26.2. Managing and Treatment
14.26.3. Health,
14.26.4. Wellness and Prevention
14.26.5. Clinical Trials
14.27. Latin America Global Connected Wearable Patches Attractiveness Analysis
14.27.1. By Product Type
14.27.2. By Application
14.28. PEST Analysis
15. Company Profiles
15.1. Market Share Analysis, By Company
15.2. Competition Matrix
15.3. Company Profiles: Key Player
15.3.1. iRhythm
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Business Strategy
15.3.1.4. Recent Developments
15.3.1.5. Manufacturing Footprint
15.3.2. Sensium Healthcare
15.3.3. Vancive Medical
15.3.4. Medtronic/Zephyr Technology
15.3.5. G-Tech Medical
15.3.6. Gentag Inc.
15.3.7. Preventice Inc.
15.3.8. Proteus Digital Health
15.3.9. DexCom
15.3.10. Abbott Laboratories
15.3.11. Bloomlife
15.3.12. Chrono Therapeutics
15.3.13. Dexcom
15.3.14. Eccrine systems
15.3.15. Feeligreen
15.3.16. Gentag
15.3.17. G-Tech Medical
15.3.18. Isansys Lifecare
15.3.19. Kenzen
15.3.20. Leaf Healthcare
15.3.21. MC10
15.3.22. Medtronic
15.3.23. Nemaura Medical
15.3.24. Philips Healthcare
15.3.25. Preventice Technologies
15.3.26. Proteus Digital
15.3.27. Qualcomm Life
15.3.28. TempTraq (Blue Spark Technologies)
15.3.29. Theranica Bio-Electronics
15.3.30. Vancive Medical Technologies
15.3.31. VitalConnect
16. Primary Key Insights
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
Best quality reports based on various authentic and accurate data findings.
Your personal and confidential information is safe and secure.
Trends Market Research © Copyright 2020. All Rights Reserved.